JPRN-UMIN000005113
Completed
Phase 4
Evaluation of the clinical remission and its sustainment after discontinuation of infliximab in patients with rheumatoid arthritis who receive "programmed" treatment in randomized controlled trial - Remission induction by Raising the dose of Remicade in RA study (RRRR Study)
niversity of Occupational and Environmental Health, Japan0 sites450 target enrollmentMarch 31, 2011
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Occupational and Environmental Health, Japan
- Enrollment
- 450
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) patients who use steroid over 10mg/day (prednisolone\-equivalent), 2\) SDAI \=\< 11\.0, 3\) severe infection, 4\) active tuberculosis, 5\) demyelinating disease, 6\) congestive heart failure, 7\) Patient who is lactating, pregnant, possibly pregnant or do not agree with anti\-conception during the trial and 6 month after the last administration of IFX, 8\) patients who are inadequate to enter this trial due to the other reasons by physician's judgments
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Examination of the clinical remission and functional remission in Infliximab using the increase-in-quantity protocol to TNF-alpha inhibitory drug resistance rheumatoid arthritisrheumatoid arthritisJPRN-UMIN000014311Institute of Health Biosciences, The University of Tokushima Graduate School10
Completed
Not Applicable
Objective assessment of the remission state and Predictors of sustained Remission in Rheumatoid Arthritis: leading to development of new management guidelinesISRCTN77249875niversity of Leeds (UK)100
Not yet recruiting
Not Applicable
A Study of Treatment-free remission Evaluation in Real-world chronic myeloid leukemia-Prospective observational studyKCT0007901Gachon University Gil Medical Center200
Active, not recruiting
Not Applicable
A 3-Phase Study to Evaluate Sustained Remission and Productivity Outcomes in Subjects With Early Rheumatoid Arthritis Initiated on Treatment With Etanercept Plus Methotrexate - PRIZEModerate to severe early Rheumatoid Arthritis (RA).MedDRA version: 12.0Level: LLTClassification code 10039073Term: Rheumatoid arthritisEUCTR2008-002623-85-ITWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development300
Completed
Not Applicable
The evaluation of efficacy for remission maintenance with immunomodulator following remission induction with tacrolimus in patients with moderate to severe active refractory ulcerative colitis.:mucosal healing for prognosisThe patients with moderate to severe active refractory ulcerative colitisJPRN-UMIN000004201Osaka City University, Graduate School of Medicine,Department of Gastroenterology50